Emerging drugs for endometrial cancer

Maria Gabriella Ferrandina, Giovanni Scambia, Giulia Amadio, Valeria Masciullo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

1 Citazioni (Scopus)

Abstract

From the dualistic classification that divides endometrial cancer (EC) into two types with distinct underlying molecular profiling, histopathology and clinical behavior, arises a deeper understanding of the carcinogenesis pathways. EC treatment comprises different and multimodal therapeutic approaches, such as chemotherapy, radiation therapy or combinations of novel drugs; however, few of these regimens have truly improved progression-free or survival rates in advanced and metastatic settings.
Lingua originaleEnglish
pagine (da-a)497-509
Numero di pagine13
RivistaExpert Opinion on Emerging Drugs
Volume19
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • biomarker
  • endometrial cancer
  • molecular pathway
  • target therapy

Fingerprint

Entra nei temi di ricerca di 'Emerging drugs for endometrial cancer'. Insieme formano una fingerprint unica.

Cita questo